Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer

Gastroenterology(2022)10.1053/j.gastro.2022.06.089Source: DataRank Database

A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer is a research paper published in Gastroenterology (2022). On theSindex it has a DataRank of 2.3. It has been cited 75 times, with 56 citing works in its 1-hop citation network.

N/A

2.3DataRank · unranked

Scored on demand from live citation data

Open Access75 citations · 56 citing works in its network

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 7.36)OA: bronzeTopics (23)Linked Datasets (24)DataCite Reuse (24)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 28%Citation Network 72%

Base Score Contribution

0.650

From this paper's citation signal

Citation Network Contribution

1.7

From 45 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 56 citers.

Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis
Molecular Cancer202438 citations12 referencesContributes 0.305
Diagnostic Specificity of Blood-based MicroRNA Signatures Should Be Fully Evaluated
Gastroenterology20223 citations6 referencesContributes 0.231
Promise and Perils of Blood-based Signatures for Detecting Early-Onset Colorectal Cancer
Gastroenterology20223 citations10 referencesContributes 0.139
Expanding the clinical utility of liquid biopsy by using liquid transcriptome and artificial intelligence
The Journal of Liquid Biopsy202413 citations21 referencesContributes 0.126
A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients
Gastroenterology202374 citations52 referencesContributes 0.083

Authors (16)

Goretti Hernández ORCID,Geeta G. Sharma ORCID,Yuma Wada ORCID,Jasjit K. Banwait ORCID,Natalia González ORCID

Live enrichment

PubMed:35850198 PMC:PMC9613521 OpenAlex:https://openalex.org/W4285603644

National Institutes of Health

Grant: CA72851

NCI NIH HHS

Grant: R01 CA072851

NCI NIH HHS

Grant: R01 CA184792

NCI NIH HHS

Grant: R01 CA181572

NCI NIH HHS

Grant: R01 CA227602

NCI NIH HHS

Grant: R01 CA202797

National Cancer Institute

FWCI

7.36

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.gastrojournal.org/article/S0016508522007740/pdf

publisherhttp://www.gastrojournal.org/article/S0016508522007740/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0016508522007740?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0016508522007740?httpAccept=text/plain

journalhttps://doi.org/10.1053/j.gastro.2022.06.089

Fields of Study

Colorectal Cancer Screening and DetectionGenetic factors in colorectal cancerColorectal Cancer Surgical Treatments

MeSH Terms

Liquid BiopsyCirculating MicroRNAHumansROC CurveBiomarkers, TumorColorectal NeoplasmsGene Expression ProfilingMicroRNAs

Keywords

Colorectal cancerLiquid biopsySignature (topology)MedicineBiopsyOncologyInternal medicineCancerMathematicsDiagnostic BiomarkerEarly-onset Colorectal CancerMirna Panel

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 2 of Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis

10.6084/m9.figshare.26679740.v1figshare

Additional file 2 of Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis

10.6084/m9.figshare.26679740figshare

Additional file 1 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683531.v1figshare

Additional file 1 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683531figshare

Additional file 2 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683534.v1figshare

Additional file 2 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683534figshare

Additional file 3 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683537.v1figshare

Additional file 3 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683537figshare

Additional file 4 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683540.v1figshare

Additional file 4 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683540figshare

Additional file 5 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683543.v1figshare

Additional file 5 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683543figshare

Additional file 10 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683558figshare

Additional file 6 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683546.v1figshare

Additional file 10 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683558.v1figshare

Additional file 7 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683549.v1figshare

Additional file 9 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683555.v1figshare

Additional file 6 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683546figshare

Additional file 7 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683549figshare

Additional file 8 of A proteomic classifier panel for early screening of colorectal cancer: a case control study

10.6084/m9.figshare.26683552figshare

A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (16)

Funding (7 grants)

Impact

Open Access

Topics

Linked Datasets (24)

Annotations (Europe PMC)